Rock Point Advisors, LLC Abbott Laboratories Transaction History

Rock Point Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $179,234 - $216,637	-1,756 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $7,753 - $9,454	68 Added 4.03%	1,756 $208,000
Q4 2021 Feb 09, 2022	BUY	$115.53 - $141.46 $195,014 - $238,784	1,688 New	1,688 $238,000
Q2 2021 Aug 05, 2021	SELL	$105.79 - $124.53 $178,573 - $210,206	-1,688 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $183,721 - $216,452	1,688 New	1,688 $202,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Rock Point Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Rock Point Advisors, LLC with notifications on news.